Story perspectives

Two Drugs Spark Myelin Repair in Multiple Sclerosis Models

5/14/2026

Summary

Story summary

Researchers identified two drug molecules that trigger myelin repair in multiple sclerosis models.
One drug blocks an overactive stress response in brain cells, enabling remyelination.
The drug changes scar tissue composition, removing a barrier to nerve repair.
Both agents crossed the blood-brain barrier in lab animals and produced remyelination and reduced neuroinflammation.
Tapani Koppinen will defend his doctoral thesis on 8 May 2026 at University of Helsinki, presenting findings.

1 of 1

Story summary

Researchers identified two drug molecules that trigger myelin repair in multiple sclerosis models.
One drug blocks an overactive stress response in brain cells, enabling remyelination.
The drug changes scar tissue composition, removing a barrier to nerve repair.
Both agents crossed the blood-brain barrier in lab animals and produced remyelination and reduced neuroinflammation.
Tapani Koppinen will defend his doctoral thesis on 8 May 2026 at University of Helsinki, presenting findings.